/ Print /

PHARMACY BEST PRACTICES

Top challenges in cancer careCancer drug costs remain the most critical challenge in care, among other things.
Watch list 2017: Top therapeutic areas
Watch list 2017: Top therapeutic areasFind out about the latest treatment and drug pipeline developments
Top pharmacy challenges of 2017
Top pharmacy challenges of 2017High drug prices continue to plague payers, but various contributing factors intensify the problem.
Will new autoimmune drugs address cost concerns?Find out what’s in the drug pipeline for autoimmune disease.
Top 2017 challenges healthcare executives face
Top 2017 challenges healthcare executives faceResults from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017.
Are payers optimistic about biosimilars’ savings?As more biosimilars are approved, plans and PBMs will continue to evolve their strategies regarding coverage and formulary management of these new medications.
Hodgkin lymphoma: First hematologic cancer cured with immunotherapy?Immune checkpoint inhibitors are taking the stage in treating relapsed and refractory Hodgkin lymphoma. Read more.
Four innovative models rein in pharma costs
Four innovative models rein in pharma costsPlans and PBMs are finding new ways to rein in pharmacy costs.
Integrating pharmacy benefit, medical benefit cuts costsHere’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.
Aggressive price growth pushes healthcare spending upRise in use of outpatient care and professional services contributed to quicker growth in spending for the privately insured over previous years.